UCLA researchers have discovered that a specific type of medication used to treat cardiovascular conditions such as hypertension, angina and abnormal heart rhythms may also decrease the risk of developing Parkinson’s disease. Researchers found that a specific sub-class of dihydropyridine cardiovascular medications was associated with a 26 to 30 percent decrease in the risk of Parkinson’s. The findings appear in an upcoming print edition of the journal Annals of Neurology and are currently available online.

For the full story, Click  Here